Journal
CLINICAL NUCLEAR MEDICINE
Volume 29, Issue 5, Pages 303-305Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.rlu.0000122802.64681.2d
Keywords
mixed medullary; follicular thyroid carcinoma; radioiodine
Ask authors/readers for more resources
Mixed medullary-follicular thyroid carcinoma (MMFTC) is a rare tumor with a metastatic behavior that has not been fully appreciated. Scintigraphy and radioiodine entrapment propensity of its metastases remains largely undescribed. The authors present a case of MMFTC with widespread bone and soft-tissue metastases, where every known site of metastases concentrated radioiodine intensely. The patient responded well to radioiodine therapy. The report suggests that the tumor may have a propensity to metastasize to the skeleton, and the metastases retain the ability to accumulate radioiodine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available